FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Alert Issued on Vantives Prismaflex Systems

[ Price : $8.95]

FDA alerts healthcare providers to a potentially high-risk issue involving dialysis tubing sets used with Prismaflex systems after...

Clinical Hold Lifted on GH Research Antidepressant

[ Price : $8.95]

FDA lifts a clinical hold against GH Researchs investigational antidepressant GH001, clearing the way for patient enrollment in th...

High Court Agrees to Hear Skinny Label Dispute

[ Price : $8.95]

The U.S. Supreme Court agrees to hear a patent-infringement dispute between generic drugmaker Hikma Pharmaceuticals USA, Inc. and ...

Qualgen FDA 483 Cites Quality Issues

[ Price : $8.95]

FDA inspectors cite Oklahoma-based outsourcing facility Qualgen for a wide range of manufacturing and quality control failures dur...

Pazdur, Others Concerned About Voucher Program Integrity

[ Price : $8.95]

Former FDA oncology drug leader Richard Pazdur says concerns surrounding a controversial fast-track drug review initiative under c...

Novartis Wins Breakthrough Status for Ianalumab

[ Price : $8.95]

FDA grants Novartis a breakthrough therapy designation to its experimental antibody ianalumab for treating Sjogrens disease.

BD New Breast Biopsy System Cleared

[ Price : $8.95]

FDA clears a BD 510(k) for its EnCor EnCompass Breast Biopsy and Tissue Removal System, a new platform designed to allow clinician...

8 Observations in Shilpa Medicare 483

[ Price : $8.95]

FDA releases the form FDA-483 with eight observations from an inspection at Indias Shilpa Medicare drug manufacturing facility.

Chinese Firms Asked About Counterfeit GLP-1 Drugs

[ Price : $8.95]

The ranking member of a House Select Committee on competition with China writes to three Chinese drug companies asking for detaile...

Teclistamab Cuts Myeloma Risk of Progression by 71%: J&J

[ Price : $8.95]

Johnson & Johnson reports positive results from a late-stage clinical trial showing that its bispecific antibody therapy Tecvayli ...